Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 68071-3805

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68071-3805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3805 7)

Pdp (68071 3805 7)
Label for Cyclobenzaprine Hydrochloride 7.5 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package containing 21 tablets, with each tablet described as round, white to off-white, and debossed with '021' on one side. The product is Rx only and manufactured by Rubicon Research Ltd., Thane, India.*
FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs Structure)

Image Description (Cyclobenzaprine HCl Tabs Structure)
Chemical structure diagram of cyclobenzaprine hydrochloride illustrating its molecular framework and hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.